As our FABP12 and Slug depletion experiments indicate that Survivin resides downstream of Slug, and Slug resides downstream of FABP12, we propose that addition of a FABP12 inhibitor to docetaxel treatment regimens may prevent or at least delay the development of docetaxel resistance in PCa cells. This evidence concerns the gene BIRC5 and posterior cortical atrophy.